HomeCompareMCRPF vs DIVO

MCRPF vs DIVO: Dividend Comparison 2026

MCRPF yields 127.39% · DIVO yields 6.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MCRPF wins by $19.9K in total portfolio value
10 years
MCRPF
MCRPF
● Live price
127.39%
Share price
$1.57
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$50.7K
Annual income
$32.01
Full MCRPF calculator →
DIVO
DIVO
● Live price
6.49%
Share price
$44.85
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$981.68
Full DIVO calculator →

Portfolio growth — MCRPF vs DIVO

📍 MCRPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMCRPFDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MCRPF + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MCRPF pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MCRPF
Annual income on $10K today (after 15% tax)
$10,828.03/yr
After 10yr DRIP, annual income (after tax)
$27.21/yr
DIVO
Annual income on $10K today (after 15% tax)
$552.00/yr
After 10yr DRIP, annual income (after tax)
$834.43/yr
At 15% tax rate, DIVO beats the other by $807.22/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MCRPF + DIVO for your $10,000?

MCRPF: 50%DIVO: 50%
100% DIVO50/50100% MCRPF
Portfolio after 10yr
$40.7K
Annual income
$506.85/yr
Blended yield
1.25%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MCRPF buys
0
DIVO buys
0
No recent congressional trades found for MCRPF or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMCRPFDIVO
Forward yield127.39%6.49%
Annual dividend / share$2.00$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%0%
Portfolio after 10y$50.7K$30.7K
Annual income after 10y$32.01$981.68
Total dividends collected$18.5K$8.2K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: MCRPF vs DIVO ($10,000, DRIP)

YearMCRPF PortfolioMCRPF Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$17,069$6,369.43$11,349$649.42+$5.7KMCRPF
2$23,345$5,080.49$12,833$688.83+$10.5KMCRPF
3$28,226$3,246.85$14,459$727.90+$13.8KMCRPF
4$32,036$1,834.45$16,238$766.49+$15.8KMCRPF
5$35,251$972.93$18,179$804.47+$17.1KMCRPF
6$38,219$500.27$20,293$841.71+$17.9KMCRPF
7$41,148$253.46$22,591$878.14+$18.6KMCRPF
8$44,156$127.51$25,087$913.65+$19.1KMCRPF
9$47,311$63.94$27,791$948.18+$19.5KMCRPF
10$50,655$32.01$30,718$981.68+$19.9KMCRPF

MCRPF vs DIVO: Complete Analysis 2026

MCRPFStock

MicroPort Scientific Corporation, an investment holding company, manufactures, and markets, and distributes medical devices in the People's Republic of China, North America, Europe, other Asian countries, South America, and internationally. The company's Cardiovascular Devices segment offers products and services for the treatment of coronary artery-related diseases; coronary stents and related delivery systems; and balloon catheters and accessories. Its Orthopedics Devices segment provides reconstructive joints, spine and trauma, and other professional implants and instruments. The company's Cardiac Rhythm Management Business segment offers defibrillators, cardiac resynchronization therapy devices, and pacemakers for the diagnosis, treatment, and management of heart rhythm disorders and heart failure. Its Endovascular and Peripheral Vascular Devices segment provides products and services for the interventional treatment of thoracic and abdominal aortic aneurysm, peripheral vascular diseases, aortic dissection, and other endovascular related diseases. The company's Neurovascular Devices segment offers neurovascular therapeutic and access devices for neurovascular diseases. Its Heart Valve Business segment provides VitaFlow Transcatheter aortic valve and delivery system, VitaFlow Liberty Transcatheter aortic valve implantation and retrievable delivery systems, Alwide Plus Balloon Catheter, various transcatheter aortic valve implantation, transcatheter mitral valve, transcatheter tricuspid valve, and surgical valve products. The company's Surgical Robot Business segment designs, develops, and commercializes surgical robots comprising robot ontology, control algorithm, electrical engineering, image-based navigation, and precision imaging. Its Surgical Devices segment researches and develops, manufactures, and sells surgical devices. MicroPort Scientific Corporation was founded in 1998 and is headquartered in Shanghai, the People's Republic of China.

Full MCRPF Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this MCRPF vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MCRPF vs SCHDMCRPF vs JEPIMCRPF vs OMCRPF vs KOMCRPF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.